Liz Parrish - Bioviva - Ending Ageing through Gene Therapy

February 5, 2016 (LocalOrg) - Agree or disagree with her methods, Liz Parrish and her company, Bioviva are taking gene therapy into their own hands in an attempt to circumvent the corrupt pharmaceutical monopolies, their representatives in the media and government, and shift the paradigm toward a more decentralized means of research and development.

Farmer Shares Tips For Getting Into Small-Scale Organic Farming

January 3, 2016 (Wisconsin Public Radio) - A farmer and author of a book about running a small-scale organic farming, said he has has found a way to make a good living on a one and a half acre organic farm.


Jean-Martin Fortier, author of "The Market Gardener: A Successful Grower's Handbook for Small-scale Organic Farming," said that no one really believes him when he says he does it without a conventional tractor.

To encourage others who might have thought of this type of farming, he shared a few tips on his success:

Raised beds

Fortier’s farm consists of 180 permanent raised beds. The beds are 100-feet long, 4 to 5 inch mounds of soil without a container around them.

"After every two seasons, they tend to settle down so we need to re-raise them again," Fortier said. "With shovels or with the rotary plow, a tool that takes the dirt from the aisle and shoots it on to the bed like a shovel would do."

Continue reading at Wisconsin Public Radio... 

Big-Pharma Seeks Monopoly Over Life-Changing Therapy

By dangling life-changing cures over people's heads for cartoonish figures of "1 million dollars," pharmaceutical corporations prove when they see sick, desperate, dying people, all they see is dollar signs... 

November 12, 2015 (Tony Cartalucci - LocalOrg) - Gene therapy is a game changer. It is not a treatment for diseases. It is a cure.

Image: Gene therapy works by reprogramming an ordinary virus to delivery modified genes to human cells. Once introduced, the modified genes are replicated by natural cell division. Missing or defective genes, over time, can be replaced by repaired genes, reprogramming the immune system to eradicate otherwise incurable diseases, or creating function in defective systems, curing blindness, deafness, diabetes, and even effects owed to aging. 

It is a cure for cancer, genetic defects, blindness, deafness, diabetes, even potentially aging.

It has already proven effective in clinical trials, curing people of leukemia who were otherwise certain to die, giving people their sight back, and already, there is one therapy approved for use in the European Union with several others approved in China.

The most remarkable aspect of gene therapy is that it overwrites your DNA once, then your cells replicate that new DNA each time they divide. In essence, the cure becomes a permanent part of you. One shot, one cure, for life, or close to it.

Why Haven't We Heard More About This? 

As remarkable and as promising as gene therapy is, it poses an immense threat to the established healthcare industry. A shot in clinical trials using experimental equipment that costs only 20,000 USD to produce that cures leukemia, if brought into mainstream medicine would be cheaper still, and undercut existing and ineffective"treatments" that can reach costs in the hundreds of thousands of dollars.

Gene therapy, then, is essentially a disruptive technology that brings various healthcare rackets to an abrupt halt along with all the vast wealth and unwarranted power and influence big-pharma has enjoyed over the decades.

Image: Dr. Carl June (center) led a team that developed a breakthrough gene therapy that effectively reprograms the immune system to hunt and kill leukemia cancer cells. Most of the patients, otherwise sure to die from their cancer, have gone into permanent remission. 

How can big-pharma continue on with its monopolies, wealth, and influence by curing everyone with one shot that costs almost nothing to make?

Their strategy is two-fold. First, they have intentionally dragged their feet for as long as possible until they can figure this problem out, letting people die of now curable diseases simply because they want to protect their existing business models and bottom lines.

Second, they have begun to mold public opinion through intense lobbying across the media and medical journals, ignoring the actual costs involved in producing the therapies, and instead cashing in on what they think it is worth to people, or in other words, dangling cures for crippling, deadly diseases over dying and/or desperate people's heads, and seeing how much they are willing to pay for them.